tofacitinib,upadacitinib,
pfizer,abbvie
['tofa', 'axspa']
2022 asas-eular recommendation lit review in abs 0413 at #acr22 shows new evidence on education &amp; exercise and confirms efficacy in axspa. tofa, upa, fil have shown efficacy in r-axspa. 
Passionately curious rheumatologist, world traveler, wife, mother, sister, daughter, friend, dog lover. Believer in scientific method & evidence based medicine.